<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Kasprzak, J.D.</title>
    <link>http://repub.eur.nl/res/aut/8023/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>European Association of Echocardiography recommendations for training, competence, and quality improvement in echocardiography (Article)</title>
      <link>http://repub.eur.nl/res/pub/27088/</link>
      <pubDate>2009-12-01T00:00:00Z</pubDate>
      <description>The main mission statement of the European Association of Echocardiography (EAE) is 'to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular ultrasound in Europe'. As competence and quality control issues are increasingly recognized by patients, physicians, and payers, the EAE has established recommendations for training, competence, and quality improvement in echocardiography. The purpose of this document is to provide the requirements for training and competence in echocardiography, to outline the principles of quality measurement, and to recommend a set of measures for improvement, with the ultimate goal of raising the standards of echocardiographic practice in Europe.</description>
    </item> <item>
      <title>Usefulness and limitations of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in patients with left bundle branch block. A multicentre study. (Article)</title>
      <link>http://repub.eur.nl/res/pub/12886/</link>
      <pubDate>2000-10-30T00:00:00Z</pubDate>
      <description>BACKGROUND: Patients with left bundle branch block exhibit abnormal septal
      motion which may limit the interpretation of stress echocardiograms. This
      study sought to assess the diagnostic value of dobutamine-atropine stress
      echocardiography in left bundle branch block patients. METHODS AND
      RESULTS: Sixty-four left bundle branch block patients (mean age 59 years,
      24 men) with suspected coronary artery disease underwent
      dobutamine-atropine stress echocardiography and coronary arteriography.
      Myocardial ischaemia was defined as new or worsening wall thickening
      abnormalities. Coronary artery disease was quantitatively defined as a
      diameter stenosis &gt;/=50% in a major epicardial artery. Rest septal motion
      was normal (apart from the early systolic septal notch) in 34 patients
      (53%) and abnormal in 30 patients (47%). Rest septal thickening was normal
      in 32 patients (50%) and abnormal in 32 patients (50%). All seven patients
      with a QRS duration &gt;/=160 ms and an abnormal QRS axis had abnormal rest
      septal motion and thickening. Inter-observer agreement for ischaemia was
      88%. In all but one patient disagreement was in the septum. For the
      anterior and posterior circulation, respectively, sensitivity was 60%
      (9/15) and 67% (8/12), specificity was 94% (46/49) and 98% (51/52), and
      accuracy was 86% (55/64) and 92% (59/64). Sensitivity for the anterior
      circulation tended to be better in patients with normal rest septal
      thickening (83% vs 44%). CONCLUSIONS: Dobutamine-atropine stress
      echocardiography has excellent diagnostic specificity in left bundle
      branch block patients with suspected coronary artery disease. In patients
      with abnormal rest septal thickening, however, dobutamine-atropine stress
      echocardiography may lack good sensitivity for detection of coronary
      artery disease in the anterior circulation. Left bundle branch block
      patients who potentially most benefit from dobutamine-atropine stress
      echocardiography may initially be selected by their resting
      electrocardiogram.</description>
    </item> <item>
      <title>Safety and prognostic value of early dobutamine-atropine stress echocardiography in patients with spontaneous chest pain and a non-diagnostic electrocardiogram. (Article)</title>
      <link>http://repub.eur.nl/res/pub/12831/</link>
      <pubDate>2000-03-04T00:00:00Z</pubDate>
      <description>AIMS: To risk stratify and shorten hospital stay in patients with
      spontaneous (resting) chest pain and a non-diagnostic electrocardiogram
      (ECG). METHODS AND RESULTS: The study comprised 102 patients (mean age
      58+/-12 years, 67 men) with spontaneous chest pain and a non-diagnostic
      ECG. Forty-three patients had suspected coronary artery disease and 59 had
      known (but of unknown actual significance) coronary artery disease. All
      patients underwent serial creatine kinase enzyme measurements, continuous
      ECG monitoring for at least 12 h and early dobutamine-atropine stress
      echocardiography in patients with negative creatine kinase enzymes and
      normal findings at ECG monitoring. Dobutamine-atropine stress
      echocardiography was considered positive in patients with new or worsening
      wall thickening abnormalities. Patients with negative dobutamine-atropine
      stress echocardiography were discharged after the test. In-hospital and 6
      month follow-up events noted were cardiac death, non-fatal myocardial
      infarction, unstable angina, and coronary artery bypass surgery or
      angioplasty. Thirteen patients had evidence of evolving myocardial
      infarction by elevated creatine kinase enzymes, or unstable angina by ECG
      monitoring. In the remaining 89 patients, dobutamine-atropine stress
      echocardiography was performed after a median observation period of 31 h
      (range 12-68 h). During dobutamine-atropine stress echocardiography no
      serious complications (death, non-fatal myocardial infarction, sustained
      ventricular tachycardia or ventricular fibrillation) occurred.
      Dobutamine-atropine stress echocardiography results were of poor quality
      in three, non-diagnostic in six, negative in 44 and positive in 36
      patients. In the 80 patients with diagnostic dobutamine-atropine stress
      echocardiography, variables associated with in-hospital events (n=7) were
      history of exertional angina (P&lt;0. 005), chest pain score (P&lt;0.005),
      stress-induced angina (P&lt;0.001) and positive dobutamine-atropine stress
      echocardiography (P&lt;0.005). Variables associated with follow-up events
      (n=11) were history of exertional angina (P&lt;0.05), chest pain score
      (P&lt;0.001), stress-induced angina (P&lt;0.01) and positive dobutamine-atropine
      stress echocardiography (P&lt;0.01). At multivariate analysis the only
      significant predictor of events was positive dobutamine-atropine stress
      echocardiography (P&lt;0.01). CONCLUSION: Early dobutamine-atropine stress
      echocardiography may safely distinguish between low- and high-risk subsets
      for subsequent cardiac events in patients with spontaneous chest pain and
      a non-diagnostic ECG.</description>
    </item>
  </channel>
</rss>